2017 - Transplantation Science Symposium

This page contains exclusive content for the member of the following sections: TTS, CTS, IPITA, ISODP, IXA, ITA, TID, IHCTAS, IPTA. Log in to view.

Tailored Immunosuppression and Chronic Rejection

8.44 - Augmented Inflammatory Responses in Aging are Driven by Circulating mtDNA and Ameliorated by Senolytic Treatment

Presenter: Timm, Heinbokel, Boston, United States


Timm Heinbokel 0; Midas Seyda 0,0; Markus Quante 0; Guangxiang Liu 0; Hirofumi Uehara 0; JeroenM. Schuitenmaker 0; Reza Abdi 0; ChristineS. Falk 0; Abdala Elkhal 0; StefanG. Tullius 0

0Division of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, United States; 2Institute of Transplant Immunology, Hannover Medical School, Hannover, United States; 3Renal Division, Schuster Family Transplant Center, Brigham and Women's Hospital, Boston, MA, United States

Introduction: Older donor organs are increasingly utilized to close the gap between demand and supply. We submit that aging-associated kinetics of damage associated molecular patterns (DAMPs) such as mitochondrial DNA (mtDNA) drive the augmented susceptibility of older organs to ischemia and reperfusion injury (IRI).

Methods: Old and young mice underwent bilateral clamping of the renal pedicles (ischemic time, 22 min at controlled body temp.) representing an established model of IRI. MtDNA levels were tested by qPCR; Dendritic Cell (DC) and T cell activation was characterized by FACS. Old or young DCs were adoptively transferred into young recipients that subsequently received young or old cardiac allografts (Hx).

Results: DC maturation was associated with elevated levels of circulating mtDNA in naïve old mice. Young animals, in contrast, had no detectable mtDNA levels (n=5/group; p=0.016). Importantly, renal IRI induced the release of mtDNA into the circulation in an age-dependent fashion with elevated amounts in old animals (n=3-5/group by POD 2; p=0.019). At the same time, old animals showed an increased IFN-γ expression in splenic CD8+ T cells (n=4-5/group by POD 2; p=0.0001). DCs co-cultured with old plasma DNA demonstrated an up-regulation of the co-stimulatory molecules CD40 and CD80. Moreover, DCs showed a dose-dependent up-regulation of CD40 and augmented amounts of IL-6 in the presence of isolated mtDNA, while the addition of a TLR9 antagonist attenuated the up-regulation. Old DCs also promoted IFN-g and IL-17 responses of allogeneic T cells in vitro. In vivo, adoptive transfer of old but not young DCs prior to Hx reduced cardiac allograft survival (median graft survival: 11.5 d Y-Hx vs. 10 d O-Hx vs. 9 d O-Hx + O-DCs; Log-rank test: p<0.0001; n=8-10/group). Finally, treatment of old mice with either Navitoclax, a senolytic agent, or a TLR9 antagonist prior to IRI reduced IFN-γ expression in splenic CD8+ T cells (n=4-5/group by POD 2; p<0.05).

Conclusion: These results suggest that aging increases mtDNA levels, favoring DC activation which can orchestrate pro-inflammatory T cell responses affecting the survival of older grafts.

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6